Compare Pfizer with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUN PHARMA PFIZER/
SUN PHARMA
 
P/E (TTM) x 49.7 70.2 70.8% View Chart
P/BV x 7.3 3.5 205.5% View Chart
Dividend Yield % 6.1 0.6 1,020.3%  

Financials

 PFIZER   SUN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-20
SUN PHARMA
Mar-20
PFIZER/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs4,930484 1,018.4%   
Low Rs2,798315 887.5%   
Sales per share (Unadj.) Rs470.3136.9 343.6%  
Earnings per share (Unadj.) Rs111.317.4 637.7%  
Cash flow per share (Unadj.) Rs133.926.0 514.7%  
Dividends per share (Unadj.) Rs330.004.00 8,250.0%  
Dividend yield (eoy) %8.51.0 853.4%  
Book value per share (Unadj.) Rs742.2188.7 393.4%  
Shares outstanding (eoy) m45.752,399.34 1.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x8.22.9 281.3%   
Avg P/E ratio x34.722.9 151.6%  
P/CF ratio (eoy) x28.915.4 187.8%  
Price / Book Value ratio x5.22.1 245.7%  
Dividend payout %296.522.9 1,293.6%   
Avg Mkt Cap Rs m176,754958,894 18.4%   
No. of employees `000NANA-   
Total wages/salary Rs m3,64563,624 5.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m21,517328,375 6.6%  
Other income Rs m1,8406,516 28.2%   
Total revenues Rs m23,357334,891 7.0%   
Gross profit Rs m5,72767,135 8.5%  
Depreciation Rs m1,03220,528 5.0%   
Interest Rs m1103,027 3.6%   
Profit before tax Rs m6,42550,096 12.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,3348,228 16.2%   
Profit after tax Rs m5,09141,868 12.2%  
Gross profit margin %26.620.4 130.2%  
Effective tax rate %20.816.4 126.4%   
Net profit margin %23.712.8 185.6%  
BALANCE SHEET DATA
Current assets Rs m30,483316,542 9.6%   
Current liabilities Rs m8,734157,064 5.6%   
Net working cap to sales %101.148.6 208.1%  
Current ratio x3.52.0 173.2%  
Inventory Days Days70158 44.3%  
Debtors Days Days3105 2.8%  
Net fixed assets Rs m13,565334,230 4.1%   
Share capital Rs m4582,399 19.1%   
"Free" reserves Rs m33,497450,245 7.4%   
Net worth Rs m33,955452,645 7.5%   
Long term debt Rs m020,289 0.0%   
Total assets Rs m44,048650,772 6.8%  
Interest coverage x59.417.5 338.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.5 96.8%   
Return on assets %11.86.9 171.2%  
Return on equity %15.09.2 162.1%  
Return on capital %19.211.2 171.3%  
Exports to sales %1.80-   
Imports to sales %1.90-   
Exports (fob) Rs m398NA-   
Imports (cif) Rs m411NA-   
Fx inflow Rs m39874,219 0.5%   
Fx outflow Rs m41127,964 1.5%   
Net fx Rs m-1446,255 -0.0%   
CASH FLOW
From Operations Rs m3,23265,548 4.9%  
From Investments Rs m15,303-25,888 -59.1%  
From Financial Activity Rs m-1,635-57,151 2.9%  
Net Cashflow Rs m16,900-13,857 -122.0%  

Share Holding

Indian Promoters % 0.0 54.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 16.5 33.3 49.6%  
FIIs % 1.9 11.7 16.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 45.5 79.3%  
Shareholders   145,980 709,045 20.6%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ORTIN LABS   MESCO PHARMA  GSK PHARMA  RPG LIFE SCIENCES  MEDICAMEN BI  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover from Day's Low to End Flat; Adani Ports and Bajaj Auto Among Top Gainers(Closing)

Indian share markets recouped early losses during closing hours and ended today's volatile session on a flat note.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors(Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jun 18, 2021 (Close)

TRACK PFIZER

PFIZER - ERIS LIFESCIENCES COMPARISON

COMPARE PFIZER WITH

MARKET STATS